170 related articles for article (PubMed ID: 7215416)
1. Pharmacokinetics of disopyramide in patients with imminent to moderate cardiac failure.
Landmark K; Bredesen JE; Thaulow E; Simonsen S; Amlie JP
Eur J Clin Pharmacol; 1981 Feb; 19(3):187-92. PubMed ID: 7215416
[TBL] [Abstract][Full Text] [Related]
2. Disopyramide serum and pharmacologic effect kinetics applied to the assessment of bioavailability.
Bryson SM; Whiting B; Lawrence JR
Br J Clin Pharmacol; 1978 Nov; 6(5):409-19. PubMed ID: 728284
[TBL] [Abstract][Full Text] [Related]
3. Disopyramide pharmacokinetics and bioavailability following the simultaneous administration of disopyramide and 14C-disopyramide.
Lima JJ; Haughey DB; Leier CV
J Pharmacokinet Biopharm; 1984 Jun; 12(3):289-313. PubMed ID: 6502472
[TBL] [Abstract][Full Text] [Related]
4. Disopyramide pharmacokinetics during recovery from myocardial infarction.
Bryson SM; Cairns CJ; Whiting B
Br J Clin Pharmacol; 1982 Mar; 13(3):417-21. PubMed ID: 7059444
[TBL] [Abstract][Full Text] [Related]
5. Pharmacokinetics and steady-state myocardial uptake of disopyramide in the dog.
Karim A; Kook C; Novotney RL; Zagarella J; Campion J
Drug Metab Dispos; 1978; 6(3):338-45. PubMed ID: 26556
[TBL] [Abstract][Full Text] [Related]
6. Disposition kinetics of disopyramide in patients with renal insufficiency.
Shen DD; Cunningham JL; Shudo I; Azarnoff DL
Biopharm Drug Dispos; 1980; 1(3):133-40. PubMed ID: 7448340
[TBL] [Abstract][Full Text] [Related]
7. Steady-state pharmacokinetics and bioavailability of total and unbound disopyramide in children with cardiac arrhythmias.
Chiba K; Koike K; Nakamoto M; Echizen H; Ishizawa A; Ishizaki T
Ther Drug Monit; 1992 Apr; 14(2):112-8. PubMed ID: 1585394
[TBL] [Abstract][Full Text] [Related]
8. The pharmacokinetics of disopyramide and mono-N-dealkyl-disopyramide in humans.
Aitio ML; Allonen H; Kanto J; Mäntylä R
Int J Clin Pharmacol Ther Toxicol; 1982 May; 20(5):219-26. PubMed ID: 7095921
[TBL] [Abstract][Full Text] [Related]
9. Pharmacokinetics of oral disopyramide phosphate in patients with renal impairment.
Johnston A; Henry JA; Warrington SJ; Hamer NA
Br J Clin Pharmacol; 1980 Sep; 10(3):245-8. PubMed ID: 7437241
[TBL] [Abstract][Full Text] [Related]
10. Stereoselectivity in the metabolism of disopyramide enantiomers in rat and dog.
Cook CS; Karim A; Sollman P
Drug Metab Dispos; 1982; 10(2):116-21. PubMed ID: 6124395
[TBL] [Abstract][Full Text] [Related]
11. The pharmacokinetics of disopyramide in patients with acute myocardial infarction.
Jounela AJ; Pentikäinen PJ; Oksanen K
Int J Clin Pharmacol Ther Toxicol; 1982 Jun; 20(6):276-82. PubMed ID: 7107076
[TBL] [Abstract][Full Text] [Related]
12. Pharmacokinetics of disopyramide in patients with chronic renal failure.
Francois B; Mallein R; Rondelet J; Lussignol M
Eur J Drug Metab Pharmacokinet; 1983; 8(1):85-92. PubMed ID: 6861798
[TBL] [Abstract][Full Text] [Related]
13. The absorption of disopyramide in animals determined using a stable isotope co-administration technique.
Haskins NJ; Waddell KA; Ford GC; Spalton PN; Walls CM; Forrest TJ; Palmer RF
Biomed Mass Spectrom; 1980 Feb; 7(2):80-3. PubMed ID: 7407335
[TBL] [Abstract][Full Text] [Related]
14. Pharmacokinetics of disopyramide administered by intramuscular, intravenous and oral routes to normal volunteers [proceedings].
Ashford JJ; Carmichael D; Kidner PH
Br J Pharmacol; 1979 Jul; 66(3):442P-443P. PubMed ID: 526732
[No Abstract] [Full Text] [Related]
15. Disopyramide kinetics in renal impairment: determinants of interindividual variability.
Burk M; Peters U
Clin Pharmacol Ther; 1983 Sep; 34(3):331-40. PubMed ID: 6883909
[TBL] [Abstract][Full Text] [Related]
16. [Clinical pharmacology of anti-arrhythmia agents. I. Quinidine, procainamide and disopyramide].
Witkowska M
Kardiol Pol; 1981; 24(7):505-17. PubMed ID: 7024612
[No Abstract] [Full Text] [Related]
17. The effects of urine pH and plasma protein binding on the renal clearance of disopyramide.
Cunningham JL; Shen DD; Shudo I; Azarnoff DL
Clin Pharmacokinet; 1977; 2(5):373-83. PubMed ID: 21054
[TBL] [Abstract][Full Text] [Related]
18. Disopyramide kinetics in patients with acute myocardial infarction.
Ilett KF; Madsen BW; Woods JD
Clin Pharmacol Ther; 1979 Jul; 26(1):1-7. PubMed ID: 445953
[TBL] [Abstract][Full Text] [Related]
19. Disopyramide hemodialysis and kinetics in patients requiring long-term hemodialysis.
Sevka MJ; Matthews SJ; Nightingale CH; Izard MW; Fieldman A; Chow MS
Clin Pharmacol Ther; 1981 Mar; 29(3):322-6. PubMed ID: 7471602
[TBL] [Abstract][Full Text] [Related]
20. Serum disopyramide concentrations and suppression of ventricular premature contractions.
Ueda CT; Dzindzio BS; Vosik WM
Clin Pharmacol Ther; 1984 Sep; 36(3):326-36. PubMed ID: 6467792
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
